TMBRQ Trex Wind Down
- 0.000
- 0.0000.00%
Trex Wind Down News
Express News | Trex Wind-Down Inc - on May 6 US Bankruptcy Court Confirmed Joint Chapter 11 Plan of Liquidation of Trex Wind-Down, Inc. and Its Affiliated Debtors
Timber Pharmaceuticals, Inc., a LEO Pharma Company, Presents Late-Breaking Preliminary Results of TMB-001 in Moderate-to-Severe Congenital Ichthyosis (CI) at the 2024 AAD Annual Meeting
The late-breaking session at the American Academy of Dermatology (AAD) Annual Meeting offers a first look at data from 17 adult and adolescent participants (aged 12-64 years) enrolled in the open-label maximum use arm
Timber Pharmaceuticals Announces Bankruptcy and Investment Risks
Timber Pharmaceuticals Files for Chapter 11 Bankruptcy
Timber Pharmaceuticals Announces Official Name Change
LEO Pharma Finalizes Acquisition of Key Assets From Timber Pharmaceuticals
Strategic acquisition to expand pipeline, accelerate growth, and meet unmet needs in medical dermatology. LEO Pharma today announced that it has finalized the acquisition of the strategic asset TMB-001 as well as
Global Lamellar Icthyosis Pipeline Research Report 2023 Featuring Timber Pharmaceuticals, Krystal Biotech, and Janssen
Timber Pharmaceuticals Suspended From Trading on NYSE American
Timber Pharmaceuticals Reveals Commencement Of NYSE American Delisting Proceedings: Common Stock Expected To Begin Trading On OTC Market
Timber Pharmaceuticals Reveals Commencement Of NYSE American Delisting Proceedings: Common Stock Expected To Begin Trading On OTC Market
NYSE American to Suspend Trading Immediately in Timber Pharmaceuticals, Inc. (TMBR)
NYSE American LLC ("NYSE American" or the "Exchange") announced today that the staff of NYSE Regulation has determined to immediately suspend trading in the common stock of Timber Pharmaceuticals, Inc. (the "Company") —
Timber Pharmaceuticals Receives Court Approval of Motions to Support Business Operations
Timber Pharmaceuticals (TMBR) said late Tuesday all the so-called "first day" motions related to its voluntary Chapter 11 petitions for reorganization filed on Nov. 17 were approved on an interim basi
Timber Pharmaceuticals Receives Court Approval of All "First Day" Motions Related to Vokuntary Chapter 11 Filing
Timber Pharmaceuticals Receives Court Approval of All "First Day" Motions Related to Vokuntary Chapter 11 Filing
Timber Pharmaceuticals: Received Delisting Notice From NYSE>TMBR
Timber Pharmaceuticals: Received Delisting Notice From NYSE>TMBR
Timber Pharmaceuticals: Common Stk Is Expected to Begin Trading OTC Following Suspension of Trading on NYSE >TMBR
Timber Pharmaceuticals: Common Stk Is Expected to Begin Trading OTC Following Suspension of Trading on NYSE >TMBR
Timber Pharmaceuticals Shares Fall 69% After Chapter 11 Filing, Delisting Notice
By Josh Beckerman Timber Pharmaceuticals shares were recently down 69% to 45 cents following the company's chapter 11 filing and a delisting notice from NYSE American. On Friday, shares were up 17%
NYSE American to Commence Delisting Proceedings Against Timber Pharmaceuticals, Inc. (TMBR)
NYSE American LLC ("NYSE American" or the "Exchange") announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of Timber Pharmaceuticals, Inc. (the "Company") —
Timber Pharmaceuticals Files for Chapter 11, Signs Asset-Sale Pact With LEO Pharma
By Josh Beckerman Timber Pharmaceuticals filed for chapter 11 bankruptcy protection on a day when LEO Pharma terminated a merger agreement that didn't receive a sufficient stockholder vote at a Frida
Timber Pharmaceuticals Inc Files For Voluntary Chapter 11 Bankruptcy; Timber Pharmaceuticals, Inc. Lists Both Assets And Liabilities In Range Of $1M-$10M
Timber Pharmaceuticals Inc Files For Voluntary Chapter 11 Bankruptcy; Timber Pharmaceuticals, Inc. Lists Both Assets And Liabilities In Range Of $1M-$10M
Sector Update: Health Care Stocks Slipping Late Afternoon
Health care stocks eased Friday afternoon with the NYSE Health Care Index falling 0.1% and the Health Care Select Sector SPDR Fund (XLV) down 0.2%. The iShares Biotechnology ETF (IBB) rose 0.9%. In co
Timber Pharmaceuticals Fails to Get Shareholder Approval For Merger
Timber Pharmaceuticals (TMBR) said Friday in a regulatory filing that the merger agreement with LEO US Holding was not approved by its stockholders at a special meeting held on Friday. Timber earlier
Analysis
Price Target
No Data
